+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia-Pacific In-Vitro Fertilization Market Analysis, 2020

  • PDF Icon


  • 162 Pages
  • April 2020
  • Region: Asia Pacific
  • MarkNtel Advisors LLP
  • ID: 5447775

Technological Advancements in China and India Fostering the Growth of In-Vitro Fertilization Market

Asia-Pacific In-Vitro Fertilization Market Analysis, 2020 research report depicts a deep-dive market analysis of statistics of Asia-Pacific In-Vitro Fertilization market which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end users, applications, product type, technologies, competitive benchmarking, etc.

In-vitro fertilization involves fertilization (IVF) of ovum using laboratory settings by implantations of egg in the ovary. Reasons for the growth of in-vitro fertilization are the presence of a large number of fertility clinics coupled with mushrooming surrogacy among women. Other factors catalyzing the growth of in-vitro fertilization during the forecast period are the emerging rate of the polycystic ovarian syndrome (PCOS) and the development of assisted reproductive technology (ART).

According to this research report “Asia-Pacific In-Vitro Fertilization Market Analysis, 2020”, the Asia-Pacific In-Vitro Fertilization market is anticipated to grow at a CAGR of around 11.35% during 2020-25.

Fertility Clinics are Witnessing an Exponential Growth

In 2019, fertility clinics and hospitals had collectively contributed about 80% of the Asia-Pacific IVF market share, on an account of their sophisticated and highly advanced treatments. Moreover, fertility clinics are surging in number with increasing number of patients. Thus, the fertility clinic segment is witnessing an amplified demand in recent times and is expected to gain momentum during 2020-25.

Fresh IVF Cycles Segment Bagged the Substantial Market Share

The fresh IVF cycles (non-donor) segment is currently the largest segment, accounting for more than three-fifths of the total market in 2020. As the fresh embryo IVF cycle begins with the ovarian stimulation, which is followed by the recovery of all eggs from the patient, the eggs are inserted for the creation of an embryo and are then transferred back in the patient. The remaining eggs are used as future frozen IVF cycles as stated in the research report “Asia-Pacific In-Vitro Fertilization Market Analysis, 2020”.

According to the publisher, the key players with a considerable market share in the Asia-Pacific In-Vitro Fertilization market include Adorefem Gynec Pro-Infertility Division, Cook Medical, Esco Group of Companies, Fujifilm Irvine, Ferring Pharmaceuticals, IVFtech ApS, Merck KGaA, Thermofisher Scientific, Olympus Corporation, VitroLife AB, etc.

Key Questions Answered in the Market Research Report

1. What are the key overall market statistics or market estimates (Market Overview, Market Size- By Value, Forecast Numbers, Market Segmentation, Market Shares) of Asia-Pacific In-Vitro Fertilization Market?
2. What are the region wise industry size, growth drivers and challenges key market trends?
3. What are the key innovations, technology upgrades, opportunities, regulations in the Asia-Pacific In-Vitro Fertilization Market?
4. Who are the key competitors or market players and how they perform in Asia-Pacific In-Vitro Fertilization Market on the basis of competitive benchmarking matrix?
5. What are the key results derived from the market surveys conducted during the course of Asia-Pacific In-Vitro Fertilization Market study?

Table of Contents

1. Introduction
1.1. Product Definition
1.2. Research Process
1.3. Glossary
1.4. Market Segmentation
2. Executive Summary3. Expert Verbatim- Interview Excerpts of 10 industry experts4. Additional IVF Procedures5. Legal Requirements and Framework at Regional Level
6. Asia-Pacific In-Vitro Fertilization Market Outlook, 2015-2025F
6.1. Market Size & Analysis
6.1.1. By Revenue
6.2. Market Share & Analysis
6.2.1. By Cycle Type Fresh IVF cycles Thawed IVF cycles Donor Egg IVF cycles
6.2.2. By Procedure Intra Cytoplasmic Sperm Injection (ICSI) Pre Implantation Genetic Diagnosis (PGD) Frozen embryo Transfer/Replacement (FET/FER) Others
6.2.3. By End-User Fertility Clinics Hospitals Surgical Center Clinical Research Institutes Cryobanks
6.2.4. By Product Type Devices Gamete Collection and Sorting Systems Sample Handling Systems Storage and Maintenance Systems Consumables Other IVF Equipment Reagents Embryo Culture Media Cryopreservation Media Gamete Processing Media Others Pharmaceuticals Services
6.2.5. By Country China India Japan Australia South Korea Singapore Rest of Asia-Pacific
6.2.6. By Company Revenue Shares Strategic Factorial Indexing Competitor Placement in MarkNtel Quadrant
7. Asia-Pacific In-Vitro Fertilization Market Outlook, 2015-2025F
7.1. Market Size & Analysis
7.1.1. By Revenue
8. Market Share & Analysis
8.1. By Cycle Type
8.2. By Procedure
8.3. By End-User
8.4. By Product Type
8.5. By Country
8.5.1. China
8.5.2. India
8.5.3. Japan
8.5.4. Australia
8.5.5. South Korea
8.5.6. Singapore
8.5.7. Others
9. China In-Vitro Fertilization Market Outlook, 2015-2025F
9.1. Market Size & Analysis
9.1.1. By Revenue
9.2. Market Share & Analysis
9.2.1. By End-User
9.2.2. By Product Type
10. India In-Vitro Fertilization Market Outlook, 2015-2025F
10.1. Market Size & Analysis
10.1.1. By Revenue
10.2. Market Share & Analysis
10.2.1. By End-User
10.2.2. By Product Type
11. Japan In-Vitro Fertilization Market Outlook, 2015-2025F
11.1. Market Size & Analysis
11.1.1. By Revenue
11.2. Market Share & Analysis
11.2.1. By End-User
11.2.2. By Product Type
12. Australia In-Vitro Fertilization Market Outlook, 2015-2025F
12.1. Market Size & Analysis
12.1.1. By Revenue
12.2. Market Share & Analysis
12.2.1. By End-User
12.2.2. By Product Type
13. South Korea In-Vitro Fertilization Market Outlook, 2015-2025F
13.1. Market Size & Analysis
13.1.1. By Revenue
13.2. Market Share & Analysis
13.2.1. By End-User
13.2.2. By Product Type
14. Singapore In-Vitro Fertilization Market Outlook, 2015-2025F
14.1. Market Size & Analysis
14.1.1. By Revenue
14.2. Market Share & Analysis
14.2.1. By End-User
14.2.2. By Product Type
15. Asia-Pacific In-Vitro Fertilization Dynamics
15.1. Drivers
15.2. Challenges
15.3. Impact Analysis
16. Asia-Pacific In-Vitro Fertilization Regulations, Product Standards17. Asia-Pacific In-Vitro Fertilization Value Chain Analysis18. Asia-Pacific In-Vitro Fertilization Intellectual Property Rights Analysis19. Asia-Pacific In-Vitro Fertilization Hotspots & Opportunities
20. Competition Outlook
20.1. Competitor Wise Growth Strategies
20.1.1. Product Portfolio
20.1.2. Brand Specialization
20.1.3. Target Markets
20.1.4. Research & Development
20.1.5. Strategic Alliances & Initiatives
20.2. Company Profiles
20.2.1. Adorefem Gynec Pro-Infertlity Division
20.2.2. Cook Medical
20.2.3. Esco Group of Companies
20.2.4. Fujifilm Irvine Scientific
20.2.5. Ferring Pharmaceuticals
20.2.6. IVFtech ApS
20.2.7. Merck KGaA
20.2.8. Thermofisher Scientific
20.2.9. Olympus Corporation
20.2.10. VitroLife AB
21. Disclaimer

Companies Mentioned

  • Adorefem Gynec Pro-Infertility Division
  • Cook Medical
  • Esco Group of Companies
  • Fujifilm Irvine
  • Ferring Pharmaceuticals
  • IVFtech ApS
  • Merck KGaA
  • Thermofisher Scientific
  • Olympus Corporation
  • VitroLife AB